LatestStartup And Fundraising 30 October 2026
Peptris Uses Generative AI to Tackle Undruggable Targets
Peptris Technologies, a Bengaluru biotech startup, has received an ₹86 crore grant from the Indian government and raised ₹70 crore in Series A funding. The company is applying generative AI to create pre‑clinical models aimed at targeting proteins previously considered undruggable, accelerating drug discovery pipelines and attracting investor interest.
Peptris Technologies, a Bengaluru‑based biotech firm, just secured a massive ₹86 crore government grant and a ₹70 crore Series A round. The funding will power its generative‑AI platform that designs pre‑clinical compounds for proteins long deemed “undruggable”.
- Generative AI: creates virtual molecules and predicts their behavior, cutting early‑stage R&D time.
- Funding boost: government grant + private investors signal strong confidence in AI‑driven drug pipelines.
- Goal: fast‑track treatments for hard‑to‑target diseases, positioning India as a biotech innovator.
For full details, see the Mint article here.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.